Triune Financial Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Triune Financial Partners's LLY Position: Q3 2026 in Review
Triune Financial Partners increased its Eli Lilly (LLY) stake by 1.7% in Q3 2026, buying an estimated $10.6K and bringing the position to 524 shares worth $606K. The position accounts for 0.12% of the portfolio, ranked #25.
Triune Financial Partners first reported a position in LLY in Q2 2023 and has held it in 14 quarters since. The position peaked at $617K in Q2 2026. 3,033 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Triune Financial Partners held 524 shares of Eli Lilly worth $606K as of Q3 2026.
- Triune Financial Partners bought 9 Eli Lilly shares in Q3 2026, an estimated $10.6K.
- Eli Lilly made up 0.12% of Triune Financial Partners's portfolio in Q3 2026, its #25 holding.
- Triune Financial Partners first reported a position in Eli Lilly in Q2 2023 and has held it in 14 quarters since.
- Triune Financial Partners's Eli Lilly position peaked at $617K in Q2 2026.
- 3,033 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Triune Financial Partners's 13F filing for Q3 2026, filed 3 Nov 2026.